Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

NW-G01

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
NW-G01, produced by Streptomyces alboflavus 313, is a novel cyclic hexapeptide antibiotic with many potential applications… 
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
2011
2011
NW-G01, a cyclic hexapeptide antibiotic, and 34-epi-NW-G01 were synthesized by the highly stereoselective convergent approach for… 
  • figure 1
2011
2011
NW-G03, a related cyclic hexapeptide compound of NW-G01, produced by Streptomyces alboflavus 313 
  • table 1
  • table 2
  • figure 2
  • figure 3
  • figure 5
2010
2010
Correction to: The Journal of Antibiotics (2010) 63, 231–235; doi:10.1038/ja.2010.24 The authors of the above article noted some… 
  • figure 1
2010
2010
NW-G01 is a novel cyclic hexapeptide antibiotic produced by Streptomyces alboflavus 313. Its relative structure was established… 
  • figure 1
  • table 1
  • figure 2
  • figure 3
2009
2009
NW-G01, a novel cyclic hexadepsipeptide antibiotic, was isolated by macroporous resin and silica gel column chromatography and… 
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3